M. Carmen Mir

Presentation(s):

• MP14-07: Performance of a New Risk Assessment Tool for Patients with Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy in the Targeted Therapy Era: REMARCC SCORE

  Friday, May 15, 2020
  7:00 AM – 9:00 AM